Friday, July 10, 2026
🇺🇸 FDA

Drug profile · INN

benzoic acid

NULL

benzoic acid (NULL) is a unknown.

TGA: approved
Patents linked 20
Pipeline programs 1
News articles 1
Drug details — benzoic acid
Class
—
Route
—
Patents
20
Programs
1
Data quality
0.78
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

benzoic acid (NULL) is a unknown.

Key facts

INN benzoic acid
Brand NULL
Mechanism Unknown

Mechanism of action

Unknown

Approval history

Authority Status Date
TGA approved —

Recent coverage

View all news
Axsome FDA Approval for Alzheimer's Agitation Drug
Critical impact Newsagitation associated with Alzheimer's diseaseMay 3, 2026

Axsome FDA Approval for Alzheimer's Agitation Drug

FDA · agitation associated with Alzheimer's disease · 6 min

Axsome Therapeutics has received FDA approval for a new treatment for agitation associated with Alzheimer's disease. This landmark decision addresses a critical unmet need and marks a significant step forward for the company and Alzheimer's patient care.

Dr. Priya Nandakumar

Pipeline programs

Search pipeline
  1. D9604C00001 Phase 3 · AstraZeneca · Reversal of anticoagulation effect in patients on a FXa inhi

Related patents

Browse patents

  1. US 12065432

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11052075

    Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10618877

    Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid

    Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10597384

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10233161

    Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid

    Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10076513

    Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10071081

    Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9969709

    Guanidinobenzoic acid ester compound

    Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9873677

    Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid

    Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9861617

    Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use

    Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9840499

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9776968

    Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

    Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9611230

    1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9434717

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9321725

    Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

    Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9314455

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9241934

    Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof

    Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9205088

    Compositions of 1,2,4-oxadiazol benzoic acid compounds and methods for their use

    Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9192606

    Dosage units of 3-(6-(1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9150552

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is benzoic acid?

benzoic acid (NULL) is a unknown.

What is the brand name for benzoic acid?

NULL is a marketed brand name for benzoic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.